FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Balance Sheet
Canada - TSX:FRX - CA31447P1009 - Common Stock
12.415 CAD
+0.82 (+7.12%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 1.34M | N/A | N/A | |||
| Cash Equivalents | 16.72M | 24.61M | 11.93M | 23.77M | 21.10M | |||
| Receivables | 18.00M | 13.00M | 8.81M | 1.55M | N/A | |||
| Inventories | 2.20M | 1.06M | 2.16M | 580.00K | N/A | |||
| Other Current Assets | 2.39M | 3.55M | 2.62M | 830.00K | 1.28M | |||
| Total Current Assets | 41.00M | 44.00M | 27.00M | 26.73M | 22.39M | |||
| Non-Current Assets | ||||||||
| Other Non-Current Assets | 770.00K | 822.00K | 6.00K | 210.00K | 30.00K | |||
| Total Non-Current Assets | 4.00M | 1.00M | 0.00 | 210.00K | 20.00K | |||
| TOTAL ASSETS | 45.00M | 45.00M | 27.00M | 26.94M | 22.41M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.23M | 3.43M | 3.78M | 2.22M | 880.00K | |||
| Accounts Payable | 5.94M | 3.24M | 3.78M | 2.39M | 780.00K | |||
| Other Current Liabilities | 250.00K | 250.00K | N/A | N/A | N/A | |||
| Total Current Liabilities | 8.41M | 6.92M | 7.55M | 4.61M | 1.65M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.00M | 18.00M | 30.00M | 25.00M | 5.00M | |||
| Other Non-Current Liabilities | 26.00M | 26.00M | 930.00K | -100.00K | -10.00K | |||
| Total Non-Current Liabilities | 43.59M | 44.08M | 30.45M | 24.90M | 4.99M | |||
| TOTAL LIABILITIES | 52.00M | 51.00M | 38.00M | 29.51M | 6.64M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -224.00M | -220.00M | -219.00M | -203.20M | -179.49M | |||
| Additional Paid In Capital | 69.00M | 67.00M | 62.00M | 56.80M | 53.21M | |||
| Common Shares | 146.00M | 146.00M | 144.00M | 142.59M | 140.80M | |||
| Other Shareholders' Equity | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | |||
| Shares Outstanding | 28.00M | 28.00M | 27.00M | 26.36M | 26.01M | |||
| Tangible Book Value per Share | -0.27 | -0.21 | -0.43 | -0.10 | 0.61 | |||
| Total Shareholders' Equity | -7.46M | -5.87M | -12.00M | -2.57M | 15.77M | |||
| TOTAL LIABILITIES AND EQUITY | 45.00M | 45.00M | 27.00M | 26.94M | 22.41M | |||
| Statistics | ||||||||
| Debt/Equity | -2.41 | -3.07 | -2.50 | -9.73 | 0.32 | |||
| Current Ratio | 4.88 | 6.36 | 3.58 | 5.80 | 13.57 | |||
| Return On Assets (ROA) | -26.78% | -0.98% | -59.26% | -88.01% | -77.42% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -110.02% | |||
| Return On Invested Capital (ROIC) | N/A | 4.86% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 13.74% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | 13.74% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.28